The Future Is Here … and It’s Way Cooler Than You Think

Published by Jennifer O’Connor.
2 min read

A California company named Organovo is developing a “bioprinting” technique with the hope of one day creating human organs using 3D printing. The process would use “bio-ink” made of mini tissues grown from  human cells that can be  printed into different human organs. This process has the potential to spare the lives of countless animals like pigs, who are now bred and killed so their organs can be removed for human transplantation experiments. These bioprinted organs could also be used in place of animals in drug testing.
Bio-printing

The company has already created human liver tissues that are being used for pharmaceutical testing.

What works for the animal often doesn’t work for the human, so why don’t we try, before we go to the human, an organism on the level of printed tissue?

— Gabor Forgacs, Organovo founder

Scottish researchers are also working on similar projects, specifically, creating a 3D printer that’s capable of using human stem cells to form different  human cells and tissues for drug testing and treatments tailored to individual patients—all without using animals. According to the researchers, “These [3D printed tissues] could then be used for animal-free drug development and personalised medicine.”

What You Can Do

Please ask the Food and Drug Administration to accept superior non-animal methods in place of archaic and unreliable animal tests.

JOIN US
Get urgent alerts, breaking animals rights news, and easy ways to take action for animals!
PETA bunny
This field is for validation purposes and should be left unchanged.
At least one of the following fields is required.
This field is hidden when viewing the form
This field is hidden when viewing the form
Untitled

Get the Latest Tips—Right in Your Inbox
We’ll e-mail you weekly with the latest in vegan recipes, fashion, and more!

By submitting this form, you’re acknowledging that you have read and agree to our privacy policy and agree to receive e-mails from us.